Showing 2091-2100 of 2314 results for "".
- A New Artificial Eye Mimics and May Outperform Human Eyeshttps://modernod.com/news/a-new-artificial-eye-mimics-and-may-outperform-human-eyes/2477815/Scientists can’t yet rebuild someone with bionic body parts. They don’t have the technology. But a new artificial eye brings cyborgs one step closer to reality, according to a report in Science N
- Politics Around Hydroxychloroquine Hamper Sciencehttps://modernod.com/news/politics-around-hydroxychloroquine-hamper-science/2477807/Publicity around the drug hydroxychloroquine spiked this week when President Donald Trump revealed that he’s taking it to prevent COVID-19. All the attention on the drug in recent months is increasingly spilling into science, and making it harder for some researchers to actually study wheth
- Early Data Show Moderna’s COVID-19 Vaccine Generates Immune Responseshttps://modernod.com/news/first-covid-19-vaccine-tested-in-the-us-shows-promise-in-data-from-eight-people/2477791/Moderna reported positive interim data from a phase 1 study of its vaccine candidate against SARS-CoV-2, with results showing that mRNA-1273 elicited neutralizing antibody titer levels in all eight initial participants in the low- and mid-dose cohorts, reaching or exceeding levels generally seen
- Samsung Bioepis Announces 24-Week Interim Results From a Phase 3 Trial of Ranibizumab Biosimilarhttps://modernod.com/news/samsung-bioepis-announces-24-week-interim-results-from-a-phase-3-trial-of-ranibizumab-biosimilar/2477785/Samsung Bioepis announced that the primary endpoints have been met in the randomized, double-masked, phase 3 trial comparing the efficacy, safety and immunogenicity of SB11, a ranibizumab biosimilar candidate, to reference ranibizumab in patients with wet age-related macular degeneration (AMD).</
- RegeneRx Joint Venture Announces Efficacy Results of Neurotrophic Keratopathy Phase 3 Clinical Trial with RGN-259https://modernod.com/news/regenerx-joint-venture-announces-efficacy-results-of-neurotrophic-keratopathy-phase-3-clinical-trial-with-rgn-259/2477764/ReGenTree LLC, a US joint venture company owned by GtreeBNT Co. and RegeneRx Biopharmaceuticals, announced the results of a randomized, double masked, placebo-controlled phase 3 clinical trial (SEER-1) using RGN-259 for the treatment of neurotrophic keratopathy (NK).
- Trump to Name Former GlaxoSmithKline Executive to Head “Warp Speed” Coronavirus Vaccine Effort: Reportshttps://modernod.com/news/trump-to-name-former-glaxosmithkline-executive-to-head-warp-speed-coronavirus-vaccine-effort-reports/2477765/According to White House officials cited in several reports Wednesday, President Donald Trump is expected to appoint Moncef Slaoui, the former chairman of GlaxoSmithKline’s vaccines division, as chief adviser of Operation Warp Speed, an initiative aimed at speeding up the search for a coron
- Stoke Therapeutics Presents Preclinical Data on Potential Treatment For Inherited Optic Nerve Disorderhttps://modernod.com/news/stoke-therapeutics-presents-preclinical-data-on-potential-treatment-for-inherited-optic-nerve-disorder/2477751/Stoke Therapeutics announced new preclinical data demonstrating in-vitro and in-vivo target engagement and protein upregulation in OPA1 protein-deficient cells. OPA1 protein deficiency is the primary cause of autosomal dominant optic atrophy (ADOA), the most common inherited optic nerve disorde
- 1-800 Contacts Launches Online Glasses Lens Replacement Brand, Boomerang Lenseshttps://modernod.com/news/covid-19-weekly-review/2477734/1-800 Contacts unveiled Boomerang, an online lens replacement service that provides new lenses for consumers to put in their current glasses without having to visit an eye doctor or optical shop. As the current health crisis began to unfold, and eyecare providers and optical shops began f
- FDA Increases Oversight, Requirements for COVID-19 Antibody Testshttps://modernod.com/news/fda-increases-oversight-requirements-for-covid-19-antibody-tests/2477723/After allowing unreviewed antibody tests to pervade the U.S. market for weeks, the FDA is closing its open-door policy for coronavirus blood serology tests—bringing their oversight more in line with the molecular diagnostics used to confirm active cases of COVID-19, according to a Fierc
- Pfizer Begins Human Testing for Experimental Coronavirus Vaccine In the UShttps://modernod.com/news/pfizer-begins-human-testing-for-experimental-coronavirus-vaccine-in-the-us/2477710/Pfizer said Tuesday it has begun testing an experimental vaccine to combat the coronavirus in the United States. The U.S.-based pharmaceutical giant, which is working alongside German drugmaker BioNTech, said the first human participants in the United States have been dosed with the potential vac